Nang Kuang Pharmaceutical Co., Ltd. (1752.TW)
TWD 41.8
(2.45%)
TWD 41.8
(2.45%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.85 Billion TWD | 7.58% |
| 2022 | 3.58 Billion TWD | 4.54% |
| 2021 | 3.42 Billion TWD | 5.18% |
| 2020 | 3.26 Billion TWD | -0.83% |
| 2019 | 3.28 Billion TWD | 8.58% |
| 2018 | 3.02 Billion TWD | -9.19% |
| 2017 | 3.33 Billion TWD | 5.11% |
| 2016 | 3.17 Billion TWD | 4.16% |
| 2015 | 3.04 Billion TWD | 10.52% |
| 2014 | 2.75 Billion TWD | 5.71% |
| 2013 | 2.6 Billion TWD | 7.9% |
| 2012 | 2.41 Billion TWD | 15.42% |
| 2011 | 2.09 Billion TWD | 13.04% |
| 2010 | 1.85 Billion TWD | 8.46% |
| 2009 | 1.7 Billion TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 3.6 Billion TWD | -6.57% |
| 2024 Q2 | 3.63 Billion TWD | 0.88% |
| 2023 Q4 | 3.85 Billion TWD | 0.35% |
| 2023 Q1 | 3.62 Billion TWD | 1.25% |
| 2023 FY | 3.85 Billion TWD | 7.58% |
| 2023 Q2 | 3.7 Billion TWD | 1.97% |
| 2023 Q3 | 3.84 Billion TWD | 3.84% |
| 2022 Q3 | 3.38 Billion TWD | -0.99% |
| 2022 FY | 3.58 Billion TWD | 4.54% |
| 2022 Q4 | 3.58 Billion TWD | 5.99% |
| 2022 Q2 | 3.41 Billion TWD | 0.62% |
| 2022 Q1 | 3.39 Billion TWD | -0.99% |
| 2021 Q2 | 3.29 Billion TWD | 1.84% |
| 2021 Q3 | 3.32 Billion TWD | 0.82% |
| 2021 FY | 3.42 Billion TWD | 5.18% |
| 2021 Q4 | 3.42 Billion TWD | 3.17% |
| 2021 Q1 | 3.23 Billion TWD | -0.71% |
| 2020 Q4 | 3.26 Billion TWD | 0.76% |
| 2020 Q2 | 3.5 Billion TWD | 2.11% |
| 2020 FY | 3.26 Billion TWD | -0.83% |
| 2020 Q3 | 3.23 Billion TWD | -7.7% |
| 2020 Q1 | 3.43 Billion TWD | 4.42% |
| 2019 Q1 | 3.01 Billion TWD | -0.41% |
| 2019 Q4 | 3.28 Billion TWD | 7.14% |
| 2019 FY | 3.28 Billion TWD | 8.58% |
| 2019 Q3 | 3.06 Billion TWD | 3.43% |
| 2019 Q2 | 2.96 Billion TWD | -1.62% |
| 2018 Q2 | 3.22 Billion TWD | -1.57% |
| 2018 Q3 | 3.15 Billion TWD | -2.12% |
| 2018 FY | 3.02 Billion TWD | -9.19% |
| 2018 Q1 | 3.27 Billion TWD | -1.76% |
| 2018 Q4 | 3.02 Billion TWD | -4.06% |
| 2017 Q3 | 3.27 Billion TWD | -0.97% |
| 2017 Q4 | 3.33 Billion TWD | 1.84% |
| 2017 FY | 3.33 Billion TWD | 5.11% |
| 2017 Q1 | 3.17 Billion TWD | -0.06% |
| 2017 Q2 | 3.3 Billion TWD | 4.28% |
| 2016 Q4 | 3.17 Billion TWD | 2.49% |
| 2016 FY | 3.17 Billion TWD | 4.16% |
| 2016 Q3 | 3.09 Billion TWD | 1.69% |
| 2016 Q2 | 3.04 Billion TWD | 0.3% |
| 2016 Q1 | 3.03 Billion TWD | -0.35% |
| 2015 Q3 | 2.96 Billion TWD | 0.51% |
| 2015 Q4 | 3.04 Billion TWD | 2.71% |
| 2015 FY | 3.04 Billion TWD | 10.52% |
| 2015 Q1 | 2.87 Billion TWD | 4.39% |
| 2015 Q2 | 2.95 Billion TWD | 2.55% |
| 2014 Q2 | 2.56 Billion TWD | -0.74% |
| 2014 Q1 | 2.58 Billion TWD | -0.68% |
| 2014 Q4 | 2.75 Billion TWD | 5.22% |
| 2014 Q3 | 2.61 Billion TWD | 1.92% |
| 2014 FY | 2.75 Billion TWD | 5.71% |
| 2013 Q4 | 2.6 Billion TWD | 3.51% |
| 2013 Q1 | 2.4 Billion TWD | -0.56% |
| 2013 Q2 | 2.5 Billion TWD | 4.16% |
| 2013 Q3 | 2.51 Billion TWD | 0.64% |
| 2013 FY | 2.6 Billion TWD | 7.9% |
| 2012 FY | 2.41 Billion TWD | 15.42% |
| 2012 Q1 | 2.19 Billion TWD | 4.95% |
| 2012 Q4 | 2.41 Billion TWD | 2.27% |
| 2012 Q3 | 2.36 Billion TWD | 3.12% |
| 2012 Q2 | 2.29 Billion TWD | 4.27% |
| 2011 Q3 | 2 Billion TWD | 5.28% |
| 2011 FY | 2.09 Billion TWD | 13.04% |
| 2011 Q1 | 1.92 Billion TWD | 4.18% |
| 2011 Q2 | 1.9 Billion TWD | -1.37% |
| 2011 Q4 | 2.09 Billion TWD | 4.5% |
| 2010 Q4 | 1.85 Billion TWD | 0.0% |
| 2010 FY | 1.85 Billion TWD | 8.46% |
| 2009 FY | 1.7 Billion TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Maxigen Biotech Inc. | 1.49 Billion TWD | -158.286% |
| SciVision Biotech Inc. | 2.16 Billion TWD | -78.512% |
| Bionime Corporation | 5.3 Billion TWD | 27.25% |
| Pegavision Corporation | 13.85 Billion TWD | 72.175% |
| Visco Vision Inc. | 4.72 Billion TWD | 18.37% |